Artificial Intelligence In Healthcare Diagnosis Market Scope And Analysis

  • Report Code : TIPRE00011852
  • Category : Technology, Media and Telecommunications
  • No. of Pages : 150
Buy Now

Artificial Intelligence in Healthcare Diagnosis Market Analysis and Scope (2024 to 2031)

Buy Now


Artificial Intelligence in Healthcare Diagnosis Market Report Scope

Report Attribute Details
Market size in 2021 US$ 7.43 Billion
Market Size by 2031 US$ 193.09 Billion
Global CAGR (2023 - 2031) 38.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Diagnostic Tool
  • Medical Imaging Tool
  • Automated Detection System
By Application
  • Eye Care
  • Oncology
  • Radiology
  • Cardiovascular
By End User
  • Hospital and Clinic
  • Diagnostic Laboratory
  • Home Care
By Service
  • Tele-Consultation
  • Tele Monitoring
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Microsoft
  • Koninklijke Philips N V
  • Intel Corporation
  • General Electric Company
  • Alphabet Inc
  • NVIDIA CORPORATION
  • Nuance Communications Inc
  • Siemens Healthineers AG
  • Arterys Inc
  • Johnson and Johnson Services Inc
  • Artificial Intelligence in Healthcare Diagnosis Market News and Recent Developments

    The artificial intelligence in healthcare diagnosis market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for artificial intelligence in healthcare diagnosis and strategies:

    • In May 2023, Digital Diagnostics launched its LumineticsCore Al diagnostic system in the southeast region of the US. LumineticsCore is a De Novo FDA-cleared autonomous AI diagnostic system (Source: Company Press Release)
    • In December 2021, F. Hoffmann-La Roche Ltd launched its artificial intelligence (AI) based digital pathology algorithms to aid pathologists in evaluating breast cancer markers, Ki-67, ER and PR. (Source: Company Press Release)

    Artificial Intelligence in Healthcare Diagnosis Market Report Coverage and Deliverables

    The “Artificial Intelligence in Healthcare Diagnosis Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles